Career 4.90 ERA, hasn't made 30 starts since 2019, pitched 13 innings last year, $10m. This off-season is going to be wild.

It isn't the high price of stars that is expensive, it's the high price of mediocrity.

Bill Veeck must be rolling over in his grave

Tyler Anderson got $8 last year; Heaney, coming off a 75 ERA+ year, got $8.5. Lyles 1/7, Paxton 1/10, Pineda 1/5.5, Cobb 2/20, Smyly 1/5.25, Wacha 1/7 ... yet somehow Quintana just 1/2 (where there incentives at least?).

So 1/10 for Boyd sure seems like a lot but for now I'll write it off to Tiger incompetence.

Maybe the Tigers' magic metrics are winning percentage and ERA. By those standards, Boyd is coming off an OUTSTANDING year.

Matt Boyd, IIRC, like Kendal Graveman, was a late round senior sign by Alex Anthopoulos whose main attractive quality was that he would sign for 1K so that the Jays could try to game the system by trying to sign guys like Tyler Beede, Phil Bickford, Daniel Norris and Anthony Alford way overslot.

Boyd and Graveman didn’t do their part though, as they didn't just take their one thousand dollar check and then retire after half a year of complex ball.

Despite accomplishing most of their MLB success outside Toronto, these two really outperformed all the Alex Anthopoulos era Jays pitchers not named Marcus Stroman.

#3 - RE: Quintana.

His 2021 was dreadful. Before that season he got a 1/$8 from the Angels and was dreadful. Like so, so bad.

So, the 1/$2 was reasonable after the debacle of 2021.

As an aside - Quintana v. 2021 and Quintana v. 2022 is exactly why I’m holding my breath on Tyler Anderson v. 2023. The Angels sure know how to get the worst out of some of these middling starters.

We shall see.

I like this deal.

Boyd was OK to good '16-20 (averaged 2.1 fWAR/2.3 bWAR), horrible in the Covid year, good til he got hurt in '21 (1.3 WAR in just 73 IP), and OK in 13 IP last year coming off surgery.

It's a 1 year deal - if he's healthy and as good as any year except '20, he's a steal for $10M.

I wasn't suggesting Quintana was underpaid exactly. I'm just ogling Paxton who threw 20 innings in 2020, 1.1 in 2021 and managed 0.2 in 2022 ... but according to b-r I mis-transcribed and he got 2/$10. The amount of money spent on the "he used to be somebody" pitching market always astounds me. I'm not sure it works out badly -- certainly some of these guys pay off every year -- it just seems "hasn't really pitched since 2019" or "had a 45 ERA+ last year" ought to be at least an orange cone if not a full-blown red flag. Seems to me those guys should, at best, generally get something like $2 with incentives that bring it up to $8 ... and I say that only because $2 seems such a trivial amount in today's game.

It's a 1 year deal - if he's healthy and as good as any year except '20, he's a steal for $10M.

Right, but the Tigers ain't going to win in 2023. Better to offer him 3/25 or something, so if he is good you get some value.

The Tigers can trade him at the deadline for good prospects if he’s performing. Boyd needs a guaranteed starting slot to set up his trade into contention at the deadline. Detroit offered one, where a contender might not have.

The Tigers can trade him at the deadline for good prospects if he’s performing.

You're not getting a good prospect for a guy like Boyd off of a half-season.

He signed for $75,000, not $1,000. And the only player more valuable than him from that round to date is Adam Frazier, who looks cooked enough that Boyd could pass him